Domtar has signed an agreement to buy privately-held Attends Healthcare Limited, a European supplier of adult incontinence products in Europe, from Rutland Partners for $235 million. In August, Domtar bought the North American arm of Attends from KPS Capital Partners for $315 million.
“This acquisition of Attends Europe moves us further along the path we started down last summer and it consolidates our ownership of the Attends brand on both sides of the Atlantic. With this acquisition, we are adding another platform for growth with a well-established business that has the critical mass to drive product development and brand growth with our current North American business,” says John Williams, president and CEO of Domtar. “Demand for incontinence care products in Europe is strong and our intent is to double earnings within the next five years.”
Attends Europe sells and markets a complete line of branded and private label adult incontinence care products. The company distributes its products in several channels with its own sales organizations in nine European countries. Attends Europe operates a 374,000 square foot manufacturing facility with eight production lines, a research and development center and distribution plant in Aneby, Sweden as well as distribution centers in Scotland and Germany. Attends has 413 employees and had sales of $180 million last year.
James Steele, current CEO of Attends Healthcare Ltd., will continue his current role. The acquired business will be integrated into the personal care segment of Domtar’s financial reporting.